• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

BREAKING: Medtronic expands Class I recall of MiniMed 600 series insulin pumps

October 5, 2021 By Sean Whooley

Medtronic Minimed 630g
Medtronic’s MiniMed 630G insulin pump [Image courtesy of Medtronic]
The FDA today announced that Medtronic (NYSE:MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps.

Medtronic today notified customers by email and phone that the recall has been expanded to replace all MiniMed 600 series insulin pumps that contain the clear container ring.

The Fridley, Minnesota-based company first warned of safety problems with the pumps in November 2019. The recall initially involved 322,005 MiniMed 630G and MiniMed 670G pumps in the U.S.

FDA confirmed that the recall covers MiniMed Model 630G pumps distributed between September 2016 and February 2020, as well as MiniMed Model 670G pumps distributed between May 2015 and December 2020. In total, 463,464 devices have now been recalled in the U.S.

Serious injuries and deaths have been reported with the use of MiniMed 600 series insulin pumps, but those events may not have been directly related to the damaged clear retainer rings that constitute the basis of this particular recall, the FDA said.

Medtronic is recalling the affected pumps to replace any pump that has a clear retainer ring with one that has an updated black retainer ring at no charge, even if the clear retainer ring is not damaged and regardless of warranty status. Medtronic previously identified and informed customers about missing or broken clear retainer rings in the pumps.

MiniMed’s retainer ring helps to lock the insulin cartridge into place in the pump’s reservoir compartment. If the cartridge is not firmly locked, under- or over-delivery of insulin may occur, which could cause low blood sugar (hypoglycemia) or high blood sugar (hyperglycemia), both of which can be life-threatening.

Medtronic issued a statement saying that the review of safety data related to the MiniMed 600 series insulin pumps with clear retainer rings has not confirmed that adverse events were directly related to the damaged clear retainer rings, but that the company is “proactively accelerating our replacement plan so we can strive for the greatest possible reliability and quality in our insulin pumps and help patients optimally manage their diabetes.”

“Insulin pumps are sophisticated medical technologies that work to normalize blood glucose levels as much as possible in individuals with diabetes who don’t have the ability to produce insulin naturally,” Medtronic Diabetes CMO Dr. Robert Vigersky said in the news release. “As with all therapies, there are risks that should be considered when a patient and their healthcare provider decide to use a pump for insulin delivery rather than multiple daily injections. The totality of evidence from both controlled, large scale clinical trials and real-world studies strongly support the safety and benefits of insulin pump therapies.”

Filed Under: Auto-injectors, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls Tagged With: FDA, Medtronic, minimed

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS